Chimeric antigens for eliciting an immune response

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8029803
APP PUB NO 20040001853A1
SERIAL NO

10365620

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are the nucleotide sequences, deduced amino acid sequences as well as methods and compositions necessary to elicit immune responses against chronic Hepatitis B infections in animals and humans. Immune response is enhanced by fusing relevant viral antigens with xenotypic immunoglobulin heavy chain region through a peptide linker and producing the fusion proteins in Baculovirus expression system to incorporate high mannose glycosylation. By virtue of the antibody component, the fusion proteins bind to Fc receptors on the surface of antigen presenting cells, are taken up, processed and derived peptides are presented on MHC Class I, which elicit a CTL (Th1) response. In a similar fashion, due to cross priming and presentation on MHC Class II, will elicit a humoral (Th2) response. In addition, disclosed are the methods of cloning, expression and production of the fusion proteins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AKSHAYA BIO INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
George, Rajan Edmonton, CA 10 162
Noujaim, Antoine Edmonton, CA 24 214
Tyrrell, Lorne Edmonton, CA 9 162

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation